Pearl Bio teams up with Merck to discover novel engineered biologics
The collaboration will initially focus on the discovery and development of biologic therapies for the treatment of cancer…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Mar 24
The collaboration will initially focus on the discovery and development of biologic therapies for the treatment of cancer…
12 Mar 24
The global collaboration and exclusive option-to-license agreement focuses on novel G protein-coupled receptor (GPCR) targets to improve patient…
29 Feb 24
Under the global licence and collaboration agreement, both firms will advance the French biotech’s OSE-230 to treat chronic…
28 Feb 24
Biological E will manufacture up to 50 million doses of the Qdenga vaccine annually, advancing Takeda’s ability to…
27 Feb 24
Neomorph will receive upfront and near-term milestone payments, R&D funding, and milestone payments, totalling $1.46bn from Novo Nordisk,…
23 Feb 24
The collaboration to leverage AbbVie's therapeutic area expertise and Tentarix's Tentacles platform, to develop novel multifunctional biologics in…
20 Feb 24
The Barcelona-based drugmaker now has the rights to develop and market the monoclonal antibody in certain fields, including…
19 Feb 24
Under the agreement, Apotex will seek market approval in Canada for VEVYE, IHEEZO, and ZERVIATE in Canada, and…
Patient CarePharmaceuticals and MedicinesPartnerships and Licensing Agreements
15 Feb 24
Brii Biosciences also agreed to acquire manufacturing capabilities and certain related assets and will also remove payment obligations…
15 Feb 24
Elsie will receive a license payment and potential development and commercial milestones